1)Nakajima T, Matsugi T, Goto W et al:New fluoroprostaglandin F(2alpha)derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents. Biol Pharm Bull 26:1691-1695, 2003
2)Takagi Y, Nakajima T, Shimazaki A et al:Pharmacological characteristics of AFP-168(tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res 78:767-776, 2004
3)桑山泰明・米虫節夫:0.0015%DE-085(タフルプロスト)の原発開放隅角緑内障または高眼圧症を対象とした0.005%ラタノプロストとの第Ⅲ相検証的試験.あたらしい眼科 25:1595-1602,2008
4)井上賢治・増本美枝子・若倉雅登・他:ラタノプロスト,トラボプロスト,タフルプロストの眼圧下降効果.あたらしい眼科 27:383-386,2010
5)石田成弘:プロスタグランジン関連薬―基礎.眼薬理 22:27-30,2008
6)Izumi N, Nagaoka T, Sato E et al:Short-term effects of topical tafluprost on retinal blood flow in cats. J Ocul Pharmacol Ther 24:521-526, 2008
7)Akaishi T, Kurashima H, Odani-Kawabata N et al:Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits. J Ocul Pharmacol Ther 26:181-186, 2010
8)Mayama C, Ishii K, Saeki T et al:Effects of topical phenylephrine and tafluprost on optic nerve head circulation in monkeys with unilateral experimental glaucoma. Invest Ophthalmol Vis Sci 51:4117-4124, 2010
9)八百枝潔・白柏基宏・阿部春樹:健常眼におけるタフルプロスト点眼前後の視神経乳頭微小循環.臨眼 64:455-458,2010
10)石垣純子・三宅三平・張野正誉・他:タフルプロスト点眼液の緑内障患者脈絡膜血流への影響の検討.あたらしい眼科 27:1115-1118,2010
11)Tamaki Y, Araie M, Tomita K et al:Real-time measurement of optic nerve head and choroid circulation, using the laser speckle phenomenon. Jpn J Ophthalmol 41:49-54, 1997
12)Yaoeda K, Shirakashi M, Funaki S et al:Measurement of microcirculation in the optic nerve head by laser speckle flowgraphy and scanning laser Doppler flowmetry. Am J Ophthalmol 129:734-739, 2000
13)Yaoeda K, Shirakashi M, Funaki S et al:Measurement of microcirculation in optic nerve head by laser speckle flowgraphy in normal volunteers. Am J Ophthalmol 130:606-610, 2000
14)Hayreh SS:Factors influencing blood flow in the optic nerve head. J Glaucoma 6:412-425, 1997
15)Grunwald JE, Piltz J, Hariprasad SM et al:Optic nerve and choroidal circulation in glaucoma. Invest Ophthalmol Vis Sci 39:2329-2336, 1998
16)Ishida N, Odani-Kawabata N, Shimazaki A et al:Prostanoids in the therapy of glaucoma. Cardiovasc Drug Rev 24:1-10, 2006
17)Stjernschantz J, Selén G, Astin M et al:Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment. Prog Retin Eye Res 19:459-496, 2000
18)Ishii K, Tomidokoro A, Nagahara M et al:Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest Ophthalmol Vis Sci 42:2957-2963, 2001
19)Dong Y, Watabe H, Su G et al:Relaxing effect and mechanism of tafluprost on isolated rabbit ciliary arteries. Exp Eye Res 87:251-256, 2008